Profile data is unavailable for this security.
About the company
Joincare Pharmaceutical Group Industry Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals and healthcare products. The Company's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The Company is also engaged in electricity business. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)16.43bn
- Net income in CNY1.42bn
- Incorporated1992
- Employees14.37k
- LocationJoincare Pharmaceutical Group Industry Co LtdJoincare Pharmaceutical Group PlazaNo.17 Langshan Road, North SectionHigh-Tech Zone, Nanshan DistrictSHENZHEN 518057ChinaCHN
- Phone+86 75 586252656
- Fax+86 75 586252165
- Websitehttps://www.joincare.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonghua Dongbao Pharmaceutical Co Ltd | 3.00bn | 1.13bn | 20.00bn | 3.20k | 17.76 | 2.71 | -- | 6.66 | 0.5682 | 0.5682 | 1.51 | 3.73 | 0.403 | 0.8622 | 4.57 | 939,125.30 | 15.20 | 18.68 | 15.84 | 19.68 | 79.89 | 78.73 | 37.71 | 39.20 | 5.04 | -- | 0.03 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Chongqing Taiji Industry Group Co Ltd | 15.40bn | 834.00m | 20.22bn | 12.59k | 24.24 | 5.22 | -- | 1.31 | 1.50 | 1.50 | 27.66 | 6.95 | 1.03 | 3.15 | 5.84 | 1,223,535.00 | 5.77 | 0.7814 | 17.83 | 2.35 | 46.14 | 44.03 | 5.62 | 0.8498 | 0.5315 | 6.12 | 0.5393 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 4.00bn | 1.02bn | 22.15bn | 1.40k | 21.59 | 3.24 | -- | 5.53 | 0.6346 | 0.6346 | 2.48 | 4.23 | 0.3813 | 0.3692 | 4.83 | 2,867,937.00 | 9.72 | 12.93 | 14.49 | 18.96 | 49.00 | 53.87 | 25.50 | 27.46 | 1.02 | -- | 0.324 | 20.30 | 0.706 | 27.25 | 2.98 | 28.26 | 42.10 | 23.27 |
| Sinocelltech Group Ltd | 2.17bn | -168.81m | 22.20bn | 2.33k | -- | -- | -- | 10.22 | -0.3791 | -0.3791 | 4.88 | -1.16 | 0.761 | 0.3743 | 6.86 | 930,592.90 | -5.93 | -40.17 | -15.48 | -74.63 | 96.35 | 95.42 | -7.79 | -108.20 | 0.4649 | 3.33 | 1.23 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.32bn | 1.38bn | 22.63bn | 12.27k | 16.23 | 1.94 | -- | 2.19 | 1.34 | 1.34 | 10.07 | 11.24 | 0.6781 | 2.85 | 5.82 | 841,054.60 | 8.87 | 8.58 | 11.67 | 11.21 | 54.25 | 58.19 | 13.08 | 11.98 | 2.15 | -- | 0.0249 | 35.91 | 6.20 | 4.44 | 12.96 | 6.60 | 21.46 | -1.63 |
| Joincare Pharmaceutical Group Ind. Co. | 16.43bn | 1.42bn | 22.68bn | 14.37k | 15.83 | 1.59 | -- | 1.38 | 0.7676 | 0.7676 | 8.86 | 7.63 | 0.4522 | 2.36 | 5.57 | 1,143,551.00 | 7.98 | 8.46 | 16.51 | 18.84 | 61.23 | 62.72 | 17.64 | 17.00 | 2.11 | -- | 0.2247 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
| Tasly Pharmaceutical Group Co Ltd | 8.64bn | 1.10bn | 23.10bn | 9.22k | 21.06 | 1.82 | -- | 2.67 | 0.7342 | 0.7342 | 5.77 | 8.47 | 0.4899 | 1.72 | 10.80 | 937,046.80 | 5.93 | 5.47 | 7.21 | 7.25 | 65.67 | 48.42 | 12.11 | 8.94 | 2.73 | 5.91 | 0.2083 | 50.99 | 0.4236 | -13.57 | 505.34 | -7.07 | -3.03 | 1.92 |
| Xiamen Amoytop Biotech Co Ltd | 2.23bn | 600.08m | 24.62bn | 1.96k | 41.02 | 12.28 | -- | 11.06 | 1.48 | 1.48 | 5.47 | 4.93 | 1.04 | 0.8541 | 6.70 | 1,135,877.00 | 28.09 | 17.96 | 32.72 | 21.02 | 93.17 | 90.48 | 26.95 | 19.17 | 3.22 | -- | 0.0037 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 8.75bn | 928.37m | 24.83bn | 8.22k | 26.21 | 2.91 | -- | 2.84 | 0.6391 | 0.6391 | 6.02 | 5.76 | 0.4511 | 1.08 | 3.46 | 1,064,162.00 | 4.76 | 5.67 | 6.90 | 8.07 | 59.44 | 60.52 | 10.55 | 11.61 | 0.8451 | 5.48 | 0.5047 | 33.55 | 0.5199 | 10.28 | -28.88 | 50.51 | 7.21 | -- |
| Shanghai Junshi Biosciences Co Ltd | 1.63bn | -2.02bn | 25.70bn | 2.57k | -- | 4.32 | -- | 15.78 | -2.06 | -2.06 | 1.66 | 6.97 | 0.1348 | 1.05 | 4.11 | 634,034.10 | -18.18 | -18.87 | -23.17 | -23.11 | 64.05 | 69.13 | -134.86 | -88.41 | 1.91 | -215.80 | 0.3018 | -- | 3.38 | 248.39 | 4.38 | -- | 8.36 | -- |
Data as of Apr 18 2024. Currency figures normalised to Joincare Pharmaceutical Group Industry Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 12.54m | 0.65% |
| Huaxia Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Jun 2023 | 11.85m | 0.62% |
| Perseverance Asset Management LPas of 30 Jun 2023 | 11.80m | 0.61% |
| China Foreign Economy & Trade Trust Co., Ltd.as of 30 Jun 2023 | 11.76m | 0.61% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 8.97m | 0.47% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 8.82m | 0.46% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 8.52m | 0.44% |
| Abu Dhabi Investment Authority (Investment Management)as of 30 Jun 2023 | 8.13m | 0.42% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 7.80m | 0.41% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 7.79m | 0.40% |
More ▼
Data from 30 Jun 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.
